Eli Lilly and Company (investor - Corporate Investor)

lilly.com

See something wrong or missing? Let us know

Offices:Indianapolis

Eli Lilly and Company is an American pharmaceutical company headquartered in Indianapolis

Average round investment:37.26M USD

Average number per year:3.8

Distribution: 2025 (4)2024 (4)2023 (5)2021 (2)

Portfolio companies: United Kingdom

Laverock Therapeutics Switzerland

Haya Therapeutics United Kingdom

Maxion Therapeutics See the entire list

Mostly invests in:

United Kingdom (8) Health services (15)

See the entire list

Showing 3 of 15 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Eli Lilly and Company mostly invests with:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Eli Lilly and Company

Name		Criteria
	OTB Ventures 83%	Range for average deal size: 20M - 50M USD Similar verticals: Health services, Manufacturing, Pharma, AI (big data), Software Services Similar business models: B2B Common investees countries: United Kingdom, Switzerland, Belgium, Netherlands Average number of deals per year: 3.5 Active last 12 months: Yes
	Novacapital 83%	Range for average deal size: 20M - 50M USD Similar verticals: Health services, Biotech, Manufacturing, AI (big data), Software Services Similar business models: B2B Common investees countries: United Kingdom, Switzerland Average number of deals per year: 3.5 Active last 12 months: Yes
	Porsche Ventures 83%	Range for average deal size: 20M - 50M USD Similar verticals: Health services, Manufacturing, AI (big data), Software Services Similar business models: B2B Common investees countries: United Kingdom, Switzerland Average number of deals per year: 3.6 Active last 12 months: Yes
	Asabys Partners 83%	Range for average deal size: 20M - 50M USD Similar verticals: Health services, Biotech, Manufacturing, Pharma, Software Services Similar business models: B2B Common investees countries: France, Belgium Average number of deals per year: 3.7 Active last 12 months: Yes
	Eiffel Investment Group 83%	Range for average deal size: 20M - 50M USD Similar verticals: Biotech, Manufacturing, AI (big data), Software Services Similar business models: B2B Common investees countries: Denmark, France Average number of deals per year: 3.9 Active last 12 months: Yes
	Boehringer Ingelheim Venture Fund 83%	Range for average deal size: 20M - 50M USD Similar verticals: Health services, Biotech, Manufacturing, Pharma, AI (big data), Software Services Similar business models: B2B Common investees countries: United Kingdom, France, Switzerland, Belgium Average number of deals per year: 3.9 Active last 12 months: Yes
	Kibo Ventures 83%	Range for average deal size: 20M - 50M USD Similar verticals: Health services, Biotech, Manufacturing, AI (big data), Software Services Similar business models: B2B Common investees countries: United Kingdom Average number of deals per year: 3.9 Active last 12 months: Yes
	Flat Capital 83%	Range for average deal size: 20M - 50M USD Similar verticals: Health services, Manufacturing, AI (big data), Software Services Similar business models: B2B Common investees countries: United Kingdom Average number of deals per year: 2.9 Active last 12 months: Yes
	V-Bio Ventures 83%	Range for average deal size: 20M - 50M USD Similar verticals: Health services, Biotech, Manufacturing, Pharma Similar business models: B2B Common investees countries: Denmark, France, Belgium, Netherlands Average number of deals per year: 2.6 Active last 12 months: Yes
	Aviva Ventures 83%	Range for average deal size: 20M - 50M USD Similar verticals: Health services, Manufacturing, Software Services Similar business models: B2B Common investees countries: United Kingdom, France Average number of deals per year: 2.5 Active last 12 months: Yes